Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Improved overall survival in dual compared to single immune checkpoint inhibitors in BRAF V600-negative advanced melanomaMelanoma Manag 2022 Apr 26;9(1)MMT60, A Kartolo, C Yeung, M Kuksis, W Hopman, T Baetz
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.